143 related articles for article (PubMed ID: 34339514)
1. The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study.
Sharma N; Sharma P; Basu S; Saxena S; Chawla R; Dushyant K; Mundeja N; Marak Z; Singh S; Singh G; Rustagi R
Trans R Soc Trop Med Hyg; 2022 Mar; 116(3):242-251. PubMed ID: 34339514
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Seroprevalence in Delhi, India, During September-October 2021: A Population-Based Seroepidemiological Study.
Sharma P; Basu S; Mishra S; Gupta E; Agarwal R; Kale P; Mundeja N; Charan BS; Singh G; Singh M
Cureus; 2022 Jul; 14(7):e27428. PubMed ID: 36051724
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
Murhekar MV; Bhatnagar T; Selvaraju S; Rade K; Saravanakumar V; Vivian Thangaraj JW; Kumar MS; Shah N; Sabarinathan R; Turuk A; Anand PK; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Rangaraju C; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Salim Khan SM; Haq I; Kumar MS; Laxmaiah A; Madhuka ; Mahapatra A; Mitra A; Nirmala AR; Pagdhune A; Qurieshi MA; Ramarao T; Sahay S; Sharma YK; Shrinivasa MB; Shukla VK; Singh PK; Viramgami A; Wilson VC; Yadav R; Girish Kumar CP; Luke HE; Ranganathan UD; Babu S; Sekar K; Yadav PD; Sapkal GN; Das A; Das P; Dutta S; Hemalatha R; Kumar A; Narain K; Narasimhaiah S; Panda S; Pati S; Patil S; Sarkar K; Singh S; Kant R; Tripathy S; Toteja GS; Babu GR; Kant S; Muliyil JP; Pandey RM; Sarkar S; Singh SK; Zodpey S; Gangakhedkar RR; S Reddy DC; Bhargava B
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):48-60. PubMed ID: 32952144
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India.
Agarwal D; Patil R; Roy S; Kaur H; Mehandale S; Bavdekar A; Nair H; Juvekar S; Dayma G;
J Glob Health; 2023 Apr; 13():06011. PubMed ID: 37079274
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.
Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Kumar MS; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Turuk A; Asthana S; Balachandar R; Bangar SD; Bansal AK; Chopra V; Das D; Deb AK; Devi KR; Dhikav V; Dwivedi GR; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Rangaraju C; Turuk J; Yadav R; Andhalkar R; Arunraj K; Bharadwaj DK; Bharti P; Bhattacharya D; Bhat J; Chahal AS; Chakraborty D; Chaudhury A; Deval H; Dhatrak S; Dayal R; Elantamilan D; Giridharan P; Haq I; Hudda RK; Jagjeevan B; Kalliath A; Kanungo S; Krishnan NN; Kshatri JS; Kumar A; Kumar N; Kumar VGV; Lakshmi GGJN; Mehta G; Mishra NK; Mitra A; Nagbhushanam K; Nimmathota A; Nirmala AR; Pandey AK; Prasad GV; Qurieshi MA; Reddy SD; Robinson A; Sahay S; Saxena R; Sekar K; Shukla VK; Singh HB; Singh PK; Singh P; Singh R; Srinivasan N; Varma DS; Viramgami A; Wilson VC; Yadav S; Yadav S; Zaman K; Chakrabarti A; Das A; Dhaliwal RS; Dutta S; Kant R; Khan AM; Narain K; Narasimhaiah S; Padmapriyadarshini C; Pandey K; Pati S; Patil S; Rajkumar H; Ramarao T; Sharma YK; Singh S; Panda S; Reddy DCS; Bhargava B;
Int J Infect Dis; 2021 Jul; 108():145-155. PubMed ID: 34022338
[TBL] [Abstract][Full Text] [Related]
7. Trend in seroprevalence of SARS-CoV-2 (IgG antibody) among tribal-dominated population: Findings from Jharkhand, India.
Mahapatra A; Palo SK; Bhattacharya D; Kanungo S; Kshatri JS; Mishra BK; Mansingh A; Parai D; Pattnaik M; Choudhary HR; Dash GC; Mohanta AR; Bishoyee A; Mohanty P; Mandal N; Dayal R; Mitra A; Pati S
Indian J Med Res; 2022 Aug; 156(2):228-239. PubMed ID: 36629182
[TBL] [Abstract][Full Text] [Related]
8. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
10. Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey.
Fofana MO; Nery N; Aguilar Ticona JP; de Andrade Belitardo EMM; Victoriano R; Anjos RO; Portilho MM; de Santana MC; Dos Santos LL; de Oliveira D; Cruz JS; Muenker MC; Khouri R; Wunder EA; Hitchings MDT; Johnson O; Reis MG; Ribeiro GS; Cummings DAT; Costa F; Ko AI
PLoS Med; 2022 Sep; 19(9):e1004093. PubMed ID: 36074784
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned.
Poljak M; Oštrbenk Valenčak A; Štrumbelj E; Maver Vodičar P; Vehovar V; Resman Rus K; Korva M; Knap N; Seme K; Petrovec M; Zupan B; Demšar J; Kurdija S; Avšič Županc T
Clin Microbiol Infect; 2021 Jul; 27(7):1039.e1-1039.e7. PubMed ID: 33838303
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys.
Kshatri JS; Bhattacharya D; Praharaj I; Mansingh A; Parai D; Kanungo S; Palo SK; Giri S; Pattnaik M; Barik SR; Dash GC; Choudhary HR; Turuk J; Mandal NN; Pati S
Epidemiol Infect; 2021 Apr; 149():e139. PubMed ID: 33902776
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among unvaccinated children of Chandigarh, Northwest India, in a household-based paediatric serosurvey post-second wave of pandemic (June to July 2021).
Ghosh A; Goyal K; Singh R; Lakshmi PVM; Kaur R; Kumar V; Muralidharan J; Puri GD; Ram J; Singh MP
Public Health; 2023 Dec; 225():160-167. PubMed ID: 37931485
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in children and adolescents in Delhi, India, from January to October 2021: a repeated cross-sectional analysis.
Sharma P; Basu S; Mishra S; Singh MM
Osong Public Health Res Perspect; 2022 Jun; 13(3):184-190. PubMed ID: 35820667
[TBL] [Abstract][Full Text] [Related]
15. High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.
Nkuba AN; Makiala SM; Guichet E; Tshiminyi PM; Bazitama YM; Yambayamba MK; Kazenza BM; Kabeya TM; Matungulu EB; Baketana LK; Mitongo NM; Thaurignac G; Leendertz FH; Vanlerberghe V; Pelloquin R; Etard JF; Maman D; Mbala PK; Ayouba A; Peeters M; Muyembe JT; Delaporte E; Ahuka SM
Clin Infect Dis; 2022 Mar; 74(5):882-890. PubMed ID: 34089598
[TBL] [Abstract][Full Text] [Related]
16. Severe acute respiratory syndrome-coronavirus-2 seroprevalence study in Pimpri-Chinchwad, Maharashtra, India coinciding with falling trend - Do the results suggest imminent herd immunity?
Banerjee A; Gaikwad B; Desale A; Jadhav SL; Rathod H; Srivastava K
Indian J Public Health; 2021; 65(3):256-260. PubMed ID: 34558487
[TBL] [Abstract][Full Text] [Related]
17. Second Wave of the COVID-19 Pandemic in Delhi, India: High Seroprevalence Not a Deterrent?
Sharma N; Sharma P; Basu S; Bakshi R; Gupta E; Agarwal R; Dushyant K; Mundeja N; Marak Z; Singh S; Singh G; Rustagi R
Cureus; 2021 Oct; 13(10):e19000. PubMed ID: 34853742
[TBL] [Abstract][Full Text] [Related]
18. Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India.
Selvaraju S; Kumar MS; Thangaraj JWV; Bhatnagar T; Saravanakumar V; Kumar CPG; Sekar K; Ilayaperumal E; Sabarinathan R; Jagadeesan M; Hemalatha MS; Murhekar MV;
Emerg Infect Dis; 2021 Feb; 27(2):586-589. PubMed ID: 33496222
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020.
Khan SMS; Qurieshi MA; Haq I; Majid S; Ahmad J; Ayub T; Bhat AA; Fazili AB; Ganai AM; Jan Y; Kaul RU; Khan ZA; Masoodi MA; Mushtaq B; Nazir F; Nazir M; Raja MW; Rasool M; Asma A; Ayoub S; Aziz M; Bhat AA; Chowdri IN; Ismail S; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Obaid M; Qazi TB; Sabah I; Sumji IA
BMJ Open; 2021 Sep; 11(9):e053791. PubMed ID: 34556519
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study.
Kumar D; Sidhu M; Dogra S; Kumar B; Sahni B; Yadav AK; Bala K; Kumari R; Mahajan R; Bavoria S; Kalotra A; Gupta S
Indian J Med Res; 2022 Jan; 155(1):171-177. PubMed ID: 35859442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
